GlassScriptPhysician profile
Ralph B Pfeiffer
NPI 1639174154
$5,179.64
in general payments reported to CMS, 2019-2025
35 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $652 · 2021: $690 · 2022: $699 · 2023: $535 · 2024: $835 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,730.21 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Silk Road Medical, INC. | $823.41 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $306.57 | 2022-2025 | Venaseal, Closurefast |
| Cardiovascular Systems INC. | $244.48 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $231.69 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Endologix LLC | $224.19 | 2024 | Alto Abdominal Stent Graft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $199.73 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $185.47 | 2021-2024 | Xarelto |
| Baxter Healthcare | $183.55 | 2020-2022 | |
| Smith+Nephew, INC. | $115.45 | 2019-2024 | Collagenase Santyl |
| Abbott Laboratories | $108.62 | 2023-2024 | Diamondback Peripheral, Diamondback Coronary, Xience Skypoint |
| Bard Peripheral Vascular, INC. | $92.08 | 2021-2024 | |
| Kerecis Limited | $71.30 | 2019-2022 | |
| Allergan, INC. | $61.25 | 2019 | |
| Tela Bio, INC. | $58.19 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $54.89 | 2024 | Restrata Wound Matrix |
| Davol INC. | $44.69 | 2022 | |
| Pfizer INC. | $41.00 | 2020-2021 | |
| Ethicon US, LLC | $39.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.64 | 2022-2024 | Gattex |
| Chiesi USA, INC. | $34.43 | 2022-2023 | Cleviprex |
| Solventum Corporation | $32.67 | 2024 | Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| Veryan Medical Incorporated | $29.73 | 2023 | Biomimics 3d Vascular Stent System |
| E.R. Squibb & Sons, L.L.C. | $29.12 | 2019 | |
| Conmed Corporation | $28.79 | 2025 | Airseal |
| Ossur Americas, INC. | $25.70 | 2025 | |
| Boston Scientific Corporation | $23.75 | 2023 | Varithena Administration Pack |
| Myriad Genetic Laboratories, INC. | $18.69 | 2021 | |
| Polynovo North America LLC | $18.58 | 2023 | |
| Z-Medica, LLC | $17.35 | 2019 | |
| Angiodynamics, INC. | $17.33 | 2021 | |
| Integra Lifesciences Corporation | $13.77 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Medtronic Vascular, INC. | $13.02 | 2019 | |
| Cook Medical LLC | $12.51 | 2024 | Zenith Alpha |
| Musculoskeletal Transplant Foundation INC. | $10.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Pfeiffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.